Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan

Daiki Tomidokoro1, Yukio Hiroi1

  • 1Department of Cardiology, National Center for Global Health and Medicine, Tokyo, Japan.

Insights

COVID-19 significantly impacts the cardiovascular system in Japan, similar to global findings. However, secondary effects on cardiovascular services in Japan were minimal during the pandemic.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has profound global health consequences.
  • Cardiovascular implications of COVID-19 are increasingly recognized.
  • Original research from Japan regarding COVID-19's cardiovascular impact is limited.

Purpose of the Study:

  • To review and validate overseas findings on COVID-19's cardiovascular implications within the Japanese clinical context.
  • To clarify the specific impacts of the pandemic on cardiovascular health in Japan.
  • To assess the secondary effects of COVID-19 on cardiovascular practice in Japan.

Main Methods:

  • Systematic review of available literature.
  • Analysis of studies focusing on Japanese patients and clinical settings.
  • Evaluation of cardiovascular complications associated with COVID-19.
  • Assessment of changes in cardiovascular service delivery and practice.

Main Results:

  • A significant association between COVID-19 and cardiovascular complications was confirmed in Japanese patients.
  • Cardiovascular manifestations in Japanese COVID-19 patients align with international observations.
  • Secondary impacts on Japanese cardiovascular practice, such as service disruptions and telemedicine adoption, were relatively minor.

Conclusions:

  • COVID-19 poses a direct threat to the cardiovascular system in Japan, necessitating awareness and tailored care.
  • International findings regarding COVID-19's cardiovascular effects are largely applicable to the Japanese healthcare setting.
  • The Japanese cardiovascular practice demonstrated resilience to secondary disruptions caused by the pandemic.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
39
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
45
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
42